company background image
GUFICBIO logo

Gufic Biosciences NSEI:GUFICBIO Stock Report

Last Price

₹432.30

Market Cap

₹43.3b

7D

0.2%

1Y

33.9%

Updated

21 Dec, 2024

Data

Company Financials

Gufic Biosciences Limited

NSEI:GUFICBIO Stock Report

Market Cap: ₹43.3b

GUFICBIO Stock Overview

Manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. More details

GUFICBIO fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Rewards

Earnings have grown 23.5% per year over the past 5 years

Risk Analysis

Has a high level of debt


My Notes

Capture your thoughts, links and company narrative

Gufic Biosciences Limited Competitors

Morepen Laboratories

BSE:500288

₹43.8b

Aarti Drugs

BSE:524348

₹39.3b

Hikal

BSE:524735

₹46.7b

Aarti Pharmalabs

NSEI:AARTIPHARM

₹51.7b

Price History & Performance

Summary of share price highs, lows and changes for Gufic Biosciences
Historical stock prices
Current Share Price₹432.30
52 Week High₹504.25
52 Week Low₹277.65
Beta0.90
1 Month Change6.58%
3 Month Change6.46%
1 Year Change33.92%
3 Year Change94.55%
5 Year Change624.12%
Change since IPO1,360.47%

Recent News & Updates

There's Reason For Concern Over Gufic Biosciences Limited's (NSE:GUFICBIO) Massive 26% Price Jump

Nov 07
There's Reason For Concern Over Gufic Biosciences Limited's (NSE:GUFICBIO) Massive 26% Price Jump

Recent updates

There's Reason For Concern Over Gufic Biosciences Limited's (NSE:GUFICBIO) Massive 26% Price Jump

Nov 07
There's Reason For Concern Over Gufic Biosciences Limited's (NSE:GUFICBIO) Massive 26% Price Jump

We Think You Should Be Aware Of Some Concerning Factors In Gufic Biosciences' (NSE:GUFICBIO) Earnings

Jun 06
We Think You Should Be Aware Of Some Concerning Factors In Gufic Biosciences' (NSE:GUFICBIO) Earnings

Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?

Jun 17
Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?

These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well

Sep 02
These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well

Should You Be Adding Gufic Biosciences (NSE:GUFICBIO) To Your Watchlist Today?

May 07
Should You Be Adding Gufic Biosciences (NSE:GUFICBIO) To Your Watchlist Today?

Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock

Dec 07
Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock

This Is The Reason Why We Think Gufic Biosciences Limited's (NSE:GUFICBIO) CEO Might Be Underpaid

Sep 15
This Is The Reason Why We Think Gufic Biosciences Limited's (NSE:GUFICBIO) CEO Might Be Underpaid

Is Now The Time To Put Gufic Biosciences (NSE:GUFICBIO) On Your Watchlist?

Aug 12
Is Now The Time To Put Gufic Biosciences (NSE:GUFICBIO) On Your Watchlist?

Gufic Biosciences' (NSE:GUFICBIO) Performance Is Even Better Than Its Earnings Suggest

Jun 11
Gufic Biosciences' (NSE:GUFICBIO) Performance Is Even Better Than Its Earnings Suggest

If You Like EPS Growth Then Check Out Gufic Biosciences (NSE:GUFICBIO) Before It's Too Late

Mar 19
If You Like EPS Growth Then Check Out Gufic Biosciences (NSE:GUFICBIO) Before It's Too Late

What Percentage Of Gufic Biosciences Limited (NSE:GUFICBIO) Shares Do Insiders Own?

Mar 01
What Percentage Of Gufic Biosciences Limited (NSE:GUFICBIO) Shares Do Insiders Own?

Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet

Feb 11
Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet

Is Gufic Biosciences' (NSE:GUFICBIO) 164% Share Price Increase Well Justified?

Jan 23
Is Gufic Biosciences' (NSE:GUFICBIO) 164% Share Price Increase Well Justified?

Why Gufic Biosciences Limited (NSE:GUFICBIO) Looks Like A Quality Company

Jan 05
Why Gufic Biosciences Limited (NSE:GUFICBIO) Looks Like A Quality Company

Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock

Dec 18
Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock

Here's What Gufic Biosciences Limited's (NSE:GUFICBIO) Shareholder Ownership Structure Looks Like

Dec 01
Here's What Gufic Biosciences Limited's (NSE:GUFICBIO) Shareholder Ownership Structure Looks Like

Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet

Nov 13
Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet

The Gufic Biosciences (NSE:GUFICBIO) Share Price Has Gained 116%, So Why Not Pay It Some Attention?

Oct 19
The Gufic Biosciences (NSE:GUFICBIO) Share Price Has Gained 116%, So Why Not Pay It Some Attention?

Can Gufic Biosciences Limited's (NSE:GUFICBIO) ROE Continue To Surpass The Industry Average?

Sep 14
Can Gufic Biosciences Limited's (NSE:GUFICBIO) ROE Continue To Surpass The Industry Average?

I Built A List Of Growing Companies And Gufic Biosciences (NSE:GUFICBIO) Made The Cut

Aug 24
I Built A List Of Growing Companies And Gufic Biosciences (NSE:GUFICBIO) Made The Cut

Investors Appear Satisfied With Gufic Biosciences Limited's (NSE:GUFICBIO) Prospects

Aug 03
Investors Appear Satisfied With Gufic Biosciences Limited's (NSE:GUFICBIO) Prospects

Earnings Tell The Story For Gufic Biosciences Limited (NSE:GUFICBIO)

Jul 09
Earnings Tell The Story For Gufic Biosciences Limited (NSE:GUFICBIO)

Shareholder Returns

GUFICBIOIN PharmaceuticalsIN Market
7D0.2%0.8%-4.2%
1Y33.9%39.7%19.1%

Return vs Industry: GUFICBIO underperformed the Indian Pharmaceuticals industry which returned 39.7% over the past year.

Return vs Market: GUFICBIO exceeded the Indian Market which returned 19.1% over the past year.

Price Volatility

Is GUFICBIO's price volatile compared to industry and market?
GUFICBIO volatility
GUFICBIO Average Weekly Movement6.7%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: GUFICBIO has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: GUFICBIO's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19701,491Pranav Choksiwww.gufic.com

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments.

Gufic Biosciences Limited Fundamentals Summary

How do Gufic Biosciences's earnings and revenue compare to its market cap?
GUFICBIO fundamental statistics
Market cap₹43.27b
Earnings (TTM)₹849.28m
Revenue (TTM)₹8.04b

51.0x

P/E Ratio

5.4x

P/S Ratio

Is GUFICBIO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GUFICBIO income statement (TTM)
Revenue₹8.04b
Cost of Revenue₹3.84b
Gross Profit₹4.20b
Other Expenses₹3.35b
Earnings₹849.28m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)8.47
Gross Margin52.28%
Net Profit Margin10.57%
Debt/Equity Ratio49.4%

How did GUFICBIO perform over the long term?

See historical performance and comparison

Dividends

0.02%

Current Dividend Yield

1%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 10:53
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gufic Biosciences Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research
Naveed MD.FirstCall Research